Research Gaps in Fragile X Syndrome: An Updated Literature Review to Inform Clinical and Public Health Practice.
Melissa Raspa, Anne Wheeler, Katherine C Okoniewski and 2 others
PMID 36219479WHAT IT FOUND
No medication or therapy has yet proven effective for the core symptoms of fragile X syndrome.
Behavioral and language interventions show promise in small studies, but the evidence base remains thin. Clinicians should prioritize early diagnosis and support for families, as specific treatments are not yet established.
Key findings
01Pharmacological trials for core symptoms have largely failed or shown only mixed results, with no current medication proven effective for the underlying condition.
02Behavioral and language interventions show promise in improving specific skills and reducing challenging behaviors, but evidence is limited to small samples and pilot studies.
03Diagnosis is typically delayed until around age 3, which limits access to early intervention services, and there is a significant gap in understanding the needs of adults with fragile X.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The review is limited to English-language articles published between 2014 and 2021. Many of the included studies, particularly on interventions, have small sample sizes, limiting the generalizability of findings. There is a significant lack of data on adults, minority populations, and the impact of environmental and social determinants of health. The review identifies gaps rather than providing new primary data, so it cannot confirm the efficacy of any specific treatment. Most intervention studies focus on very specific skills or behaviors, making it difficult to recommend broad treatment approaches.
Declared interests
The authors declare no conflict of interest.
The easy way to misread this
Do not interpret the promising results of small behavioral or pilot medication studies as evidence of established effective treatments. The review explicitly states that no pharmacological treatment has met primary endpoints for core symptoms, and behavioral interventions require large-scale replication. Current best practice remains supportive care and early diagnosis, not targeted therapeutic cures.